217 related articles for article (PubMed ID: 25399571)
1. Notch functions in developmental and tumour angiogenesis by diverse mechanisms.
Kangsamaksin T; Tattersall IW; Kitajewski J
Biochem Soc Trans; 2014 Dec; 42(6):1563-8. PubMed ID: 25399571
[TBL] [Abstract][Full Text] [Related]
2. NOTCH decoys that selectively block DLL/NOTCH or JAG/NOTCH disrupt angiogenesis by unique mechanisms to inhibit tumor growth.
Kangsamaksin T; Murtomaki A; Kofler NM; Cuervo H; Chaudhri RA; Tattersall IW; Rosenstiel PE; Shawber CJ; Kitajewski J
Cancer Discov; 2015 Feb; 5(2):182-97. PubMed ID: 25387766
[TBL] [Abstract][Full Text] [Related]
3. Notch pathway targets proangiogenic regulator Sox17 to restrict angiogenesis.
Lee SH; Lee S; Yang H; Song S; Kim K; Saunders TL; Yoon JK; Koh GY; Kim I
Circ Res; 2014 Jul; 115(2):215-26. PubMed ID: 24755984
[TBL] [Abstract][Full Text] [Related]
4. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis.
Hellström M; Phng LK; Hofmann JJ; Wallgard E; Coultas L; Lindblom P; Alva J; Nilsson AK; Karlsson L; Gaiano N; Yoon K; Rossant J; Iruela-Arispe ML; Kalén M; Gerhardt H; Betsholtz C
Nature; 2007 Feb; 445(7129):776-80. PubMed ID: 17259973
[TBL] [Abstract][Full Text] [Related]
5. Soluble Notch ligand and receptor peptides act antagonistically during angiogenesis.
Klose R; Berger C; Moll I; Adam MG; Schwarz F; Mohr K; Augustin HG; Fischer A
Cardiovasc Res; 2015 Jul; 107(1):153-63. PubMed ID: 25975260
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis.
Ridgway J; Zhang G; Wu Y; Stawicki S; Liang WC; Chanthery Y; Kowalski J; Watts RJ; Callahan C; Kasman I; Singh M; Chien M; Tan C; Hongo JA; de Sauvage F; Plowman G; Yan M
Nature; 2006 Dec; 444(7122):1083-7. PubMed ID: 17183323
[TBL] [Abstract][Full Text] [Related]
7. A novel peptide inhibitor of Dll4-Notch1 signalling and its pro-angiogenic functions.
Zhu G; Lin Y; Ge T; Singh S; Liu H; Fan L; Wang S; Rhen J; Jiang D; Lyu Y; Yin Y; Li X; Benoit DSW; Li W; Xu Y; Pang J
Br J Pharmacol; 2022 Apr; 179(8):1716-1731. PubMed ID: 34796471
[TBL] [Abstract][Full Text] [Related]
8. Synaptojanin-2 binding protein stabilizes the Notch ligands DLL1 and DLL4 and inhibits sprouting angiogenesis.
Adam MG; Berger C; Feldner A; Yang WJ; Wüstehube-Lausch J; Herberich SE; Pinder M; Gesierich S; Hammes HP; Augustin HG; Fischer A
Circ Res; 2013 Nov; 113(11):1206-18. PubMed ID: 24025447
[TBL] [Abstract][Full Text] [Related]
9. Notch signaling regulates tumor angiogenesis by diverse mechanisms.
Dufraine J; Funahashi Y; Kitajewski J
Oncogene; 2008 Sep; 27(38):5132-7. PubMed ID: 18758482
[TBL] [Abstract][Full Text] [Related]
10. New pathways and mechanisms regulating and responding to Delta-like ligand 4-Notch signalling in tumour angiogenesis.
Oon CE; Harris AL
Biochem Soc Trans; 2011 Dec; 39(6):1612-8. PubMed ID: 22103496
[TBL] [Abstract][Full Text] [Related]
11. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis.
Noguera-Troise I; Daly C; Papadopoulos NJ; Coetzee S; Boland P; Gale NW; Lin HC; Yancopoulos GD; Thurston G
Nature; 2006 Dec; 444(7122):1032-7. PubMed ID: 17183313
[TBL] [Abstract][Full Text] [Related]
12. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo.
Li JL; Sainson RC; Shi W; Leek R; Harrington LS; Preusser M; Biswas S; Turley H; Heikamp E; Hainfellner JA; Harris AL
Cancer Res; 2007 Dec; 67(23):11244-53. PubMed ID: 18056450
[TBL] [Abstract][Full Text] [Related]
13. A notch1 ectodomain construct inhibits endothelial notch signaling, tumor growth, and angiogenesis.
Funahashi Y; Hernandez SL; Das I; Ahn A; Huang J; Vorontchikhina M; Sharma A; Kanamaru E; Borisenko V; Desilva DM; Suzuki A; Wang X; Shawber CJ; Kandel JJ; Yamashiro DJ; Kitajewski J
Cancer Res; 2008 Jun; 68(12):4727-35. PubMed ID: 18559519
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implications.
Li JL; Harris AL
Front Biosci (Landmark Ed); 2009 Jan; 14(8):3094-110. PubMed ID: 19273260
[TBL] [Abstract][Full Text] [Related]
15. Role of Delta-like 4 in Jagged1-induced tumour angiogenesis and tumour growth.
Oon CE; Bridges E; Sheldon H; Sainson RCA; Jubb A; Turley H; Leek R; Buffa F; Harris AL; Li JL
Oncotarget; 2017 Jun; 8(25):40115-40131. PubMed ID: 28445154
[TBL] [Abstract][Full Text] [Related]
16. The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth.
Thurston G; Noguera-Troise I; Yancopoulos GD
Nat Rev Cancer; 2007 May; 7(5):327-31. PubMed ID: 17457300
[TBL] [Abstract][Full Text] [Related]
17. Delta-like ligand 4 regulates vascular endothelial growth factor receptor 2-driven luteal angiogenesis through induction of a tip/stalk phenotype in proliferating endothelial cells.
García-Pascual CM; Zimmermann RC; Ferrero H; Shawber CJ; Kitajewski J; Simón C; Pellicer A; Gómez R
Fertil Steril; 2013 Dec; 100(6):1768-76.e1. PubMed ID: 24074756
[TBL] [Abstract][Full Text] [Related]
18. Notch1 and Notch4 core binding domain peptibodies exhibit distinct ligand-binding and anti-angiogenic properties.
Sargis T; Youn SW; Thakkar K; Naiche LA; Paik NY; Pajcini KV; Kitajewski JK
Angiogenesis; 2023 May; 26(2):249-263. PubMed ID: 36376768
[TBL] [Abstract][Full Text] [Related]
19. DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo.
Li JL; Sainson RC; Oon CE; Turley H; Leek R; Sheldon H; Bridges E; Shi W; Snell C; Bowden ET; Wu H; Chowdhury PS; Russell AJ; Montgomery CP; Poulsom R; Harris AL
Cancer Res; 2011 Sep; 71(18):6073-83. PubMed ID: 21803743
[TBL] [Abstract][Full Text] [Related]
20. SUMOylation Negatively Regulates Angiogenesis by Targeting Endothelial NOTCH Signaling.
Zhu X; Ding S; Qiu C; Shi Y; Song L; Wang Y; Wang Y; Li J; Wang Y; Sun Y; Qin L; Chen J; Simons M; Min W; Yu L
Circ Res; 2017 Sep; 121(6):636-649. PubMed ID: 28760777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
